NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

Never questioned the science and the support of KOLs. I applauded their efforts around JAMA Oncology when it was published. But there are quite a few pharma companies that have good product and ph 3 data, but they remain a boutique operation due to stubborn and inexperienced management crew that simply are unable to do the right things at the right time. And therefore cannot build trust and credibility amongst big investors given the sketchy history!

The reality is they are not able to bring big investors that see the value of the ph 3 data as well as the progress they have made and importantly value the company over a $2-3B market cap.